Long-Acting Nanomedicine for Tuberculosis: A Mechanism-Informed Framework
International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-35
DOI: 10.2147/ijn.s641702 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Yedi Herdiana. Beteiligte Einrichtung: Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia. Hauptthemen laut MEDLINE: Nanomedicine, Antitubercular Agents, Tuberculosis. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia.
ORCID-Profile: Yedi Herdiana
Zitieren
APA
Herdiana, Y. (2026). Long-Acting Nanomedicine for Tuberculosis: A Mechanism-Informed Framework. International Journal of Nanomedicine, Volume 21, 1-35. https://doi.org/10.2147/ijn.s641702
Vancouver
Herdiana Y. Long-Acting Nanomedicine for Tuberculosis: A Mechanism-Informed Framework. International Journal of Nanomedicine. 2026;Volume 21:1-35. doi:10.2147/ijn.s641702
BibTeX
@article{Herdiana2026,
author = {Herdiana, Yedi},
title = {Long-Acting Nanomedicine for Tuberculosis: A Mechanism-Informed Framework},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--35},
doi = {10.2147/ijn.s641702}
}
EUVIMED